Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The CD28–B7 Family of Co-signaling Molecules
Shigenori Nagai, Miyuki Azuma
Advances in experimental medicine and biology (2019), pp. 25-51
Closed Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

T cells and their products in diabetic kidney disease
Yue Liu, Yaodong Lv, Tingwei Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 43
Recent Advances in Allogeneic CAR-T Cells
Dong Won Kim, Je‐Yoel Cho
Biomolecules (2020) Vol. 10, Iss. 2, pp. 263-263
Open Access | Times Cited: 99
Tumor cell membrane‐based vaccines: A potential boost for cancer immunotherapy
Muyang Yang, Jie Zhou, Liseng Lu, et al.
Exploration (2024) Vol. 4, Iss. 6
Open Access | Times Cited: 12
Recombinant CD80 fusion protein combined with discoidin domain receptor 1 inhibitor for cancer treatment
Songna Wang, Pinliang Hu, Xuyao Zhang, et al.
Applied Microbiology and Biotechnology (2025) Vol. 109, Iss. 1
Open Access | Times Cited: 1
Detection of Immune Checkpoint Receptors – A Current Challenge in Clinical Flow Cytometry
Benjamin Shibru, Katharina Fey, Stephan Fricke, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 43
Water-Soluble Chemically Precise Fluorinated Molecular Clusters for Interference-Free Multiplex 19F MRI in Living Mice
Xiaoxue Tang, Ao Li, Cuicui Zuo, et al.
ACS Nano (2023) Vol. 17, Iss. 5, pp. 5014-5024
Closed Access | Times Cited: 22
Co-expression of a PD-L1-specific chimeric switch receptor augments the efficacy and persistence of CAR T cells via the CD70-CD27 axis
Le Qin, Yuanbin Cui, Tingjie Yuan, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 26
Immune checkpoint inhibitors break whose heart? Perspectives from cardio-immuno-oncology
Yingying He, Hui Yu, Shuang Dai, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 807-818
Open Access | Times Cited: 11
Cellular and molecular regulation of the programmed death-1/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases
Jorge Ibañez-Vega, Constanza Vilchez, Karin Jimenez, et al.
Journal of Autoimmunity (2021) Vol. 123, pp. 102702-102702
Closed Access | Times Cited: 25
Gut microbiota: A double-edged sword in immune checkpoint blockade immunotherapy against tumors
Juanjuan Wang, Ningning Zhu, Lei Su, et al.
Cancer Letters (2023) Vol. 582, pp. 216582-216582
Closed Access | Times Cited: 10
Causal Characteristics of Immune Cells Associated with Aortic Dissection: A Mendelian Randomisation Analysis
Tian-le Li, M.J. Fu, Lihong Wang, et al.
European Cardiology Review (2025) Vol. 20
Open Access
Pig conceptuses secrete interferon gamma to recruit T cells to the endometrium during the peri-implantation period
Bryan A McLendon, Heewon Seo, Avery C. Kramer, et al.
Biology of Reproduction (2020) Vol. 103, Iss. 5, pp. 1018-1029
Closed Access | Times Cited: 27
B7-H3 in Medulloblastoma-Derived Exosomes; A Novel Tumorigenic Role
Ian J. Purvis, Kiran Kumar Velpula, Maheedhara R. Guda, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7050-7050
Open Access | Times Cited: 24
Elucidating different pattern of immunoregulation in BALB/c and C57BL/6 mice and their F1 progeny
Wiebke Hartmann, Birte Blankenhaus, Marie-Luise Brunn, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 21
Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use
Elisa Gotti, Sarah Tettamanti, Silvia Zaninelli, et al.
Cytotherapy (2022) Vol. 24, Iss. 3, pp. 334-343
Open Access | Times Cited: 15
Clinical Research on the Mechanisms Underlying Immune Checkpoints and Tumor Metastasis
Xiyang Tang, An‐Ping Shi, Yanlu Xiong, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 20
Epitope topography of agonist antibodies to the checkpoint inhibitory receptor BTLA
Timothy C. Cheung, S. Atwell, Lisa M. Bafetti, et al.
Structure (2023) Vol. 31, Iss. 8, pp. 958-967.e3
Open Access | Times Cited: 7
The potential of B7-H6 as a therapeutic target in cancer immunotherapy
Alaleh Mohammadi, Souzan Najafi, Mohammad Amini, et al.
Life Sciences (2022) Vol. 304, pp. 120709-120709
Closed Access | Times Cited: 12
The Role of Co-Signaling Molecules in Psoriasis and Their Implications for Targeted Treatment
Suqing Liu, Jinhua Xu, Jinfeng Wu
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 16
Chimeric CTLA4-CD28-CD3z T Cells Potentiate Antitumor Activity Against CD80/CD86–Positive B Cell Malignancies
Shouheng Lin, Lin Cheng, Wei Ye, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 15
Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection
Nuri Lee, Seri Jeong, Kibum Jeon, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
B7-H6, an immunoligand for the natural killer cell activating receptor NKp30, reveals inhibitory effects on cell proliferation and migration, but not apoptosis, in cervical cancer derived-cell lines
Nehla Banu, Annie Riera Leal, Jesse Haramati, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 14
B7-H6 as an efficient target for T cell-induced cytotoxicity in haematologic malignant cells
Xin Sun, Jingyuan Zhao, Li Ma, et al.
Investigational New Drugs (2020) Vol. 39, Iss. 1, pp. 24-33
Closed Access | Times Cited: 13
Can Soluble Immune Checkpoint Molecules on Exosomes Mediate Inflammation?
Julie Joseph, Benjamin Rahmani, Yonesha Cole, et al.
Journal of Neuroimmune Pharmacology (2021) Vol. 17, Iss. 3-4, pp. 381-397
Open Access | Times Cited: 11
Modulation of Lymphocyte Functions in the Microenvironment by Tumor Oncogenic Pathways
Barbara Seliger, Chiara Massa
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top